Dr. Hideyo MIYAZAKI, Chief Representative of ARISE
(Hospital Director, National Center for Global Health and Medicine, Japan Institute for Health Security)

As of April 1^st 2025, the National Center for Global Health and Medicine has merged with the National Institute of Infectious Diseases to form the Japan Institute for Health Security (JIHS). Our new organization, JIHS, is built on three key pillars of excellence: (1) Data Collection and Evaluation, (2) Research and Development Platform, and (3) Clinical Trials Network, which we aim to focus on both domestically and internationally.

Launched in 2021, the Academic Research Organization (ARO) Alliance for Southeast and East Asia (ARISE), aims to respond promptly to the medical needs of the population in the region. Our network focuses on conducting high-quality clinical research and providing timely access to new medicinal products for infectious diseases.

Since the 1^st of July 2024, I have served as the Director of the Center Hospital in the National Center for Global Health and Medicine (Currently, National Center for Global Health and Medicine, JIHS), and the Chief Representative for ARISE. I also lead the Japan Agency for Medical Research and Development (AMED) Clinical Research and Clinical Trial Promotion Project, which focuses on building infectious disease clinical research and trial networks in Asia.

In light of the new organization, ARISE will continue to prioritize its targeted projects and aspire to be a leading network for clinical research and trials on infectious diseases, emphasizing the promotion of high-quality trials throughout Asia.